These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33486885)

  • 21. Global timing of hepatitis C virus elimination in high-income countries.
    Razavi H; Sanchez Gonzalez Y; Yuen C; Cornberg M
    Liver Int; 2020 Mar; 40(3):522-529. PubMed ID: 31815353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research gaps in viral hepatitis.
    Boyd A; Duchesne L; Lacombe K
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.
    Scott N; McBryde ES; Thompson A; Doyle JS; Hellard ME
    Gut; 2017 Aug; 66(8):1507-1515. PubMed ID: 27196586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges on the achievement of World Health Organization goals for HCV elimination in Italy: need for a Regional programmatic approach on screening and linkage to care. Commentary.
    Kondili LA; Aghemo A; Andreoni M
    Ann Ist Super Sanita; 2021; 57(3):201-204. PubMed ID: 34554113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Crespo J; Albillos A; Buti M; Calleja JL; García Samaniego J; Hernández Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Grandados R; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G
    Rev Esp Enferm Dig; 2019 Nov; 111(11):862-873. PubMed ID: 31657609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
    Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
    Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis G; Razavi H; Hatzakis A
    J Gastroenterol Hepatol; 2017 Feb; 32(2):466-472. PubMed ID: 27403912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for simplifying and using absolute targets for viral hepatitis elimination goals.
    Polaris Observatory Collaborators
    J Viral Hepat; 2021 Jan; 28(1):12-19. PubMed ID: 32979881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons.
    Flisiak R; Zarębska-Michaluk D; Ciupkeviciene E; Drazilova S; Frankova S; Grgurevic I; Hunyady B; Jarcuska P; Kupčinskas L; Makara M; Saulite-Vanaga G; Simonova M; Sperl J; Tolmane I; Vince A
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
    Kondili LA; Robbins S; Blach S; Gamkrelidze I; Zignego AL; Brunetto MR; Raimondo G; Taliani G; Iannone A; Russo FP; Santantonio TA; Zuin M; Chessa L; Blanc P; Puoti M; Vinci M; Erne EM; Strazzabosco M; Massari M; Lampertico P; Rumi MG; Federico A; Orlandini A; Ciancio A; Borgia G; Andreone P; Caporaso N; Persico M; Ieluzzi D; Madonia S; Gori A; Gasbarrini A; Coppola C; Brancaccio G; Andriulli A; Quaranta MG; Montilla S; Razavi H; Melazzini M; Vella S; Craxì A;
    Liver Int; 2018 Dec; 38(12):2190-2198. PubMed ID: 29900654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach.
    Busschots D; Ho E; Blach S; Nevens F; Razavi H; Van Damme B; Vanwolleghem T; Robaeys G
    BMC Infect Dis; 2022 Apr; 22(1):397. PubMed ID: 35459120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
    Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
    Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
    Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
    Müllhaupt B; Bruggmann P; Bihl F; Blach S; Lavanchy D; Razavi H; Robbins Scott S; Semela D; Negro F
    PLoS One; 2018; 13(12):e0209374. PubMed ID: 30596701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action.
    Facente SN; Grinstein R; Broussard J; Shost J; Azari S; Siruno J; Jimenez JA; Luetkemeyer AF; Burk K
    Public Health Rep; 2022; 137(4):649-654. PubMed ID: 35403488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polaris Observatory-supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis.
    Razavi H
    Antivir Ther; 2022 Apr; 27(2):13596535221083179. PubMed ID: 35499176
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.